- Home
- RCMT vs NVCT Comparison
RCMT vs NVCT Comparison
Compare RCMT & NVCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RCMT
- NVCT
- Stock Information
- Founded
- RCMT 1971
- NVCT 2020
- Country
- RCMT United States
- NVCT United States
- Employees
- RCMT N/A
- NVCT N/A
- Industry
- RCMT Professional Services
- NVCT Medicinal Chemicals and Botanical Products
- Sector
- RCMT Consumer Discretionary
- NVCT Health Care
- Exchange
- RCMT Nasdaq
- NVCT Nasdaq
- Market Cap
- RCMT 172.2M
- NVCT 184.9M
- IPO Year
- RCMT N/A
- NVCT 2022
- Fundamental
- Price
- RCMT $24.60
- NVCT $8.02
- Analyst Decision
- RCMT Strong Buy
- NVCT Strong Buy
- Analyst Count
- RCMT 2
- NVCT 3
- Target Price
- RCMT $33.50
- NVCT $17.00
- AVG Volume (30 Days)
- RCMT 80.4K
- NVCT 179.3K
- Earning Date
- RCMT 08-06-2025
- NVCT 08-05-2025
- Dividend Yield
- RCMT N/A
- NVCT N/A
- EPS Growth
- RCMT N/A
- NVCT N/A
- EPS
- RCMT 1.74
- NVCT N/A
- Revenue
- RCMT $290,914,000.00
- NVCT N/A
- Revenue This Year
- RCMT $16.29
- NVCT N/A
- Revenue Next Year
- RCMT $6.16
- NVCT N/A
- P/E Ratio
- RCMT $14.15
- NVCT N/A
- Revenue Growth
- RCMT 8.53
- NVCT N/A
- 52 Week Low
- RCMT $13.18
- NVCT $4.44
- 52 Week High
- RCMT $27.24
- NVCT $11.80
- Technical
- Relative Strength Index (RSI)
- RCMT 55.47
- NVCT 49.93
- Support Level
- RCMT $22.48
- NVCT $7.56
- Resistance Level
- RCMT $27.24
- NVCT $8.27
- Average True Range (ATR)
- RCMT 1.22
- NVCT 0.39
- MACD
- RCMT 0.04
- NVCT 0.08
- Stochastic Oscillator
- RCMT 62.07
- NVCT 89.52
About RCMT RCM Technologies Inc.
RCM Technologies Inc is a provider of business and technology solutions designed to enhance and maximize the operational performance of its customers. It operates in three segments: Specialty Health Care, Engineering, and Life Sciences, Data and Solutions (LS&D). The company generates maximum revenue from the Specialty Health Care segment that provides staffing solutions including medical healthcare professionals, health information management professionals, nurses, paraprofessionals, physicians, and therapists. Geographically, it derives a majority of its revenue from the United States and also has a presence in Canada, Puerto Rico, the Philippines, and Europe.
About NVCT Nuvectis Pharma Inc.
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.